世界のレイノー病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Raynauds Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4942
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、レイノー病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・レイノー病治療の市場動向
・企業の競争状況、市場シェア
・レイノー病治療の種類別市場規模（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）
・レイノー病治療の用途別市場規模（病院、診療所、その他）
・レイノー病治療の北米市場規模2016-2027（アメリカ、カナダ）
・レイノー病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・レイノー病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・レイノー病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・レイノー病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan Plc、Apricus Biosciences, Inc.、Bayer AG、Covis Pharmaceuticals, Inc.、Human Stem Cells Institute）
・結論

Market Analysis and Insights: Global Raynauds Disease Treatment Market
The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Raynauds Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Raynauds Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Raynauds Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Raynauds Disease Treatment market.

Global Raynauds Disease Treatment Scope and Market Size
Raynauds Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Raynauds Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acetylcysteine
Alprostadil
ELS-140
Neovasculgen
Nitroglycerin
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc
Apricus Biosciences, Inc.
Bayer AG
Covis Pharmaceuticals, Inc.
Human Stem Cells Institute

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Raynauds Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acetylcysteine
1.2.3 Alprostadil
1.2.4 ELS-140
1.2.5 Neovasculgen
1.2.6 Nitroglycerin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Raynauds Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Raynauds Disease Treatment Market Perspective (2016-2027)
2.2 Raynauds Disease Treatment Growth Trends by Regions
2.2.1 Raynauds Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Raynauds Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Raynauds Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Raynauds Disease Treatment Industry Dynamic
2.3.1 Raynauds Disease Treatment Market Trends
2.3.2 Raynauds Disease Treatment Market Drivers
2.3.3 Raynauds Disease Treatment Market Challenges
2.3.4 Raynauds Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Raynauds Disease Treatment Players by Revenue
3.1.1 Global Top Raynauds Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Raynauds Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Raynauds Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Raynauds Disease Treatment Revenue
3.4 Global Raynauds Disease Treatment Market Concentration Ratio
3.4.1 Global Raynauds Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Raynauds Disease Treatment Revenue in 2020
3.5 Raynauds Disease Treatment Key Players Head office and Area Served
3.6 Key Players Raynauds Disease Treatment Product Solution and Service
3.7 Date of Enter into Raynauds Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Raynauds Disease Treatment Breakdown Data by Type
4.1 Global Raynauds Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Raynauds Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Raynauds Disease Treatment Breakdown Data by Application
5.1 Global Raynauds Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Raynauds Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Raynauds Disease Treatment Market Size (2016-2027)
6.2 North America Raynauds Disease Treatment Market Size by Type
6.2.1 North America Raynauds Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Raynauds Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Raynauds Disease Treatment Market Size by Type (2016-2027)
6.3 North America Raynauds Disease Treatment Market Size by Application
6.3.1 North America Raynauds Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Raynauds Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Raynauds Disease Treatment Market Size by Application (2016-2027)
6.4 North America Raynauds Disease Treatment Market Size by Country
6.4.1 North America Raynauds Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Raynauds Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Raynauds Disease Treatment Market Size (2016-2027)
7.2 Europe Raynauds Disease Treatment Market Size by Type
7.2.1 Europe Raynauds Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Raynauds Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Raynauds Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Raynauds Disease Treatment Market Size by Application
7.3.1 Europe Raynauds Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Raynauds Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Raynauds Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Raynauds Disease Treatment Market Size by Country
7.4.1 Europe Raynauds Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Raynauds Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Raynauds Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Raynauds Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Raynauds Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Raynauds Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Raynauds Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Raynauds Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Raynauds Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Raynauds Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Raynauds Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Raynauds Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Raynauds Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Raynauds Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Raynauds Disease Treatment Market Size (2016-2027)
9.2 Latin America Raynauds Disease Treatment Market Size by Type
9.2.1 Latin America Raynauds Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Raynauds Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Raynauds Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Raynauds Disease Treatment Market Size by Application
9.3.1 Latin America Raynauds Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Raynauds Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Raynauds Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Raynauds Disease Treatment Market Size by Country
9.4.1 Latin America Raynauds Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Raynauds Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Raynauds Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Raynauds Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Raynauds Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Raynauds Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Raynauds Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Raynauds Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Raynauds Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Raynauds Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Raynauds Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Raynauds Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Raynauds Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Raynauds Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Raynauds Disease Treatment Introduction
11.1.4 Allergan Plc Revenue in Raynauds Disease Treatment Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 Apricus Biosciences, Inc.
11.2.1 Apricus Biosciences, Inc. Company Details
11.2.2 Apricus Biosciences, Inc. Business Overview
11.2.3 Apricus Biosciences, Inc. Raynauds Disease Treatment Introduction
11.2.4 Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2016-2021)
11.2.5 Apricus Biosciences, Inc. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Raynauds Disease Treatment Introduction
11.3.4 Bayer AG Revenue in Raynauds Disease Treatment Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Covis Pharmaceuticals, Inc.
11.4.1 Covis Pharmaceuticals, Inc. Company Details
11.4.2 Covis Pharmaceuticals, Inc. Business Overview
11.4.3 Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Introduction
11.4.4 Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2016-2021)
11.4.5 Covis Pharmaceuticals, Inc. Recent Development
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Details
11.5.2 Human Stem Cells Institute Business Overview
11.5.3 Human Stem Cells Institute Raynauds Disease Treatment Introduction
11.5.4 Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2016-2021)
11.5.5 Human Stem Cells Institute Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Raynauds Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acetylcysteine
Table 3. Key Players of Alprostadil
Table 4. Key Players of ELS-140
Table 5. Key Players of Neovasculgen
Table 6. Key Players of Nitroglycerin
Table 7. Key Players of Others
Table 8. Global Raynauds Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Raynauds Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Raynauds Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Raynauds Disease Treatment Market Share by Regions (2016-2021)
Table 12. Global Raynauds Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Raynauds Disease Treatment Market Share by Regions (2022-2027)
Table 14. Raynauds Disease Treatment Market Trends
Table 15. Raynauds Disease Treatment Market Drivers
Table 16. Raynauds Disease Treatment Market Challenges
Table 17. Raynauds Disease Treatment Market Restraints
Table 18. Global Raynauds Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Raynauds Disease Treatment Market Share by Players (2016-2021)
Table 20. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynauds Disease Treatment as of 2020)
Table 21. Ranking of Global Top Raynauds Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Raynauds Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Raynauds Disease Treatment Product Solution and Service
Table 25. Date of Enter into Raynauds Disease Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Raynauds Disease Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Raynauds Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Raynauds Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Raynauds Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Raynauds Disease Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Raynauds Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Raynauds Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Raynauds Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Raynauds Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Raynauds Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Raynauds Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Raynauds Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Raynauds Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Raynauds Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Raynauds Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Raynauds Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Raynauds Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Raynauds Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Raynauds Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Raynauds Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Raynauds Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Raynauds Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Raynauds Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Raynauds Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Raynauds Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Raynauds Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Raynauds Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Raynauds Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Raynauds Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Raynauds Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Raynauds Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Raynauds Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Raynauds Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Allergan Plc Company Details
Table 66. Allergan Plc Business Overview
Table 67. Allergan Plc Raynauds Disease Treatment Product
Table 68. Allergan Plc Revenue in Raynauds Disease Treatment Business (2016-2021) & (US$ Million)
Table 69. Allergan Plc Recent Development
Table 70. Apricus Biosciences, Inc. Company Details
Table 71. Apricus Biosciences, Inc. Business Overview
Table 72. Apricus Biosciences, Inc. Raynauds Disease Treatment Product
Table 73. Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2016-2021) & (US$ Million)
Table 74. Apricus Biosciences, Inc. Recent Development
Table 75. Bayer AG Company Details
Table 76. Bayer AG Business Overview
Table 77. Bayer AG Raynauds Disease Treatment Product
Table 78. Bayer AG Revenue in Raynauds Disease Treatment Business (2016-2021) & (US$ Million)
Table 79. Bayer AG Recent Development
Table 80. Covis Pharmaceuticals, Inc. Company Details
Table 81. Covis Pharmaceuticals, Inc. Business Overview
Table 82. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Product
Table 83. Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2016-2021) & (US$ Million)
Table 84. Covis Pharmaceuticals, Inc. Recent Development
Table 85. Human Stem Cells Institute Company Details
Table 86. Human Stem Cells Institute Business Overview
Table 87. Human Stem Cells Institute Raynauds Disease Treatment Product
Table 88. Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2016-2021) & (US$ Million)
Table 89. Human Stem Cells Institute Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Raynauds Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Acetylcysteine Features
Figure 3. Alprostadil Features
Figure 4. ELS-140 Features
Figure 5. Neovasculgen Features
Figure 6. Nitroglycerin Features
Figure 7. Others Features
Figure 8. Global Raynauds Disease Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Raynauds Disease Treatment Report Years Considered
Figure 13. Global Raynauds Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Raynauds Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Raynauds Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Raynauds Disease Treatment Market Share by Regions (2022-2027)
Figure 17. Global Raynauds Disease Treatment Market Share by Players in 2020
Figure 18. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynauds Disease Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Raynauds Disease Treatment Revenue in 2020
Figure 20. Global Raynauds Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Raynauds Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Raynauds Disease Treatment Market Share by Type (2016-2027)
Figure 24. North America Raynauds Disease Treatment Market Share by Application (2016-2027)
Figure 25. North America Raynauds Disease Treatment Market Share by Country (2016-2027)
Figure 26. United States Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Raynauds Disease Treatment Market Share by Type (2016-2027)
Figure 30. Europe Raynauds Disease Treatment Market Share by Application (2016-2027)
Figure 31. Europe Raynauds Disease Treatment Market Share by Country (2016-2027)
Figure 32. Germany Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Raynauds Disease Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Raynauds Disease Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Raynauds Disease Treatment Market Share by Region (2016-2027)
Figure 42. China Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Raynauds Disease Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Raynauds Disease Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Raynauds Disease Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Raynauds Disease Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Raynauds Disease Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Raynauds Disease Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Raynauds Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan Plc Revenue Growth Rate in Raynauds Disease Treatment Business (2016-2021)
Figure 62. Apricus Biosciences, Inc. Revenue Growth Rate in Raynauds Disease Treatment Business (2016-2021)
Figure 63. Bayer AG Revenue Growth Rate in Raynauds Disease Treatment Business (2016-2021)
Figure 64. Covis Pharmaceuticals, Inc. Revenue Growth Rate in Raynauds Disease Treatment Business (2016-2021)
Figure 65. Human Stem Cells Institute Revenue Growth Rate in Raynauds Disease Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年）

Global Meningococcal Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3701 2021年4月 97Pages
QYResearch社発行の本調査資料では、髄膜炎菌性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ワクチン）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のクッシング病治療市場規模・現状・予測（2021年-2027年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1677 2021年4月 93Pages
QYResearch社発行の本調査資料では、クッシング病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）、用途別市場規模（病院薬局、小売...

世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4115 2021年4月 93Pages
QYResearch社発行の本調査資料では、ニューカッスル病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（弱毒生ワクチン、不活化ワクチン、結合型ワクチン）、用途別市場規模（獣医病院、獣医クリニック、獣医研究機関、ドラッグストア、その他）、...

世界の感染症治療市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3147 2021年4月 97Pages
QYResearch社発行の本調査資料では、感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗真菌薬、抗ウイルス薬）、用途別市場規模（病院＆クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の人獣共通感染症治療市場規模・現状・予測（2021年-2027年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z6111 2021年4月 96Pages
QYResearch社発行の本調査資料では、人獣共通感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のポンペ病治療市場規模・現状・予測（2021年-2027年）

Global Pompe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4700 2021年4月 98Pages
QYResearch社発行の本調査資料では、ポンペ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（乳児発症ポンペ病、成人発症ポンペ病）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のキャッスルマン病治療市場規模・現状・予測（2021年-2027年）

Global Castleman Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1151 2021年4月 95Pages
QYResearch社発行の本調査資料では、キャッスルマン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）、用途別市場規模（病院、臨床、外来診療ユニット...

世界のベーチェット病治療市場規模・現状・予測（2021年-2027年）

Global Behcet Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0738 2021年4月 99Pages
QYResearch社発行の本調査資料では、ベーチェット病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）、用途別市場規模（在宅医療、病院、ク...

世界の希少神経疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4940 2021年4月 97Pages
QYResearch社発行の本調査資料では、希少神経疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
世界のベーチェット病治療市場規模・現状・予測（2021年-2027年） Behcet disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. Market Analysis and Insights: Global Behcet Disease Treatment Market The global Behcet Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX…
世界のウィルソン病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Wilson's Disease Treatment Market The global Wilson's Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …